SNIPR BIOME
Phase 2We are the CRISPR Microbiome Company; Our mission is to develop CRISPR-based medicines that give hope for effective and safe treatment of difficult-to-treat diseases in the future.
Founded
2017
Focus
MicrobiomeRNA & Gene Therapy
About
We are the CRISPR Microbiome Company; Our mission is to develop CRISPR-based medicines that give hope for effective and safe treatment of difficult-to-treat diseases in the future.
Funding History
2Total raised: $60M
Series A$50MLundbeckfonden VenturesMay 15, 2021
Seed$10MLundbeckfonden VenturesJun 15, 2019
Company Info
TypePrivate
Founded2017
LocationCopenhagen, Denmark
StagePhase 2
Contact
SIMILAR COMPANIES
MipSalus
Pre-clinical · Copenhagen
FluoGuide
Pre-clinical · Copenhagen
Fuse Vectors
Pre-clinical · Copenhagen
Fida Biosystems
Pre-clinical · Copenhagen
CerCell
Pre-clinical · Copenhagen
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile